fexofenadine OTC
Selected indexed studies
- Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. (World Allergy Organ J, 2022) [PMID:35833202]
- OTC drugs for seasonal allergies. (Med Lett Drugs Ther, 2019) [PMID:31169808]
- Palatability of Crushed Over-the-Counter Medications. (J Pain Symptom Manage, 2021) [PMID:32976943]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Palatability of Crushed Over-the-Counter Medications. (2021) pubmed
- Why aren't lower, effective, OTC doses available earlier by prescription? (2003) pubmed
- OTC drugs for seasonal allergies. (2019) pubmed
- Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. (2022) pubmed
- Nonprescription medications for respiratory symptoms: Facts and marketing fictions. (2018) pubmed
- Therapeutic advantages of third generation antihistamines. (1998) pubmed
- Cost and utilization impacts of oral antihistamines in the California Medi-Cal program. (2005) pubmed
- Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study. (2024) pubmed
- Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine. (2003) pubmed